FY’26 was the strongest year in the Company’s history -delivering record performance across every key metric, while simultaneously executing the largest annual capacity expansion in its two-decade journey.
Mumbai: Park Medi World Limited, North India’s 2nd largest hospital chain (“the Company”) (NSE: PARKHOSPS, BSE: 544645) today announced its audited financial results for the quarter and year ended March 3l5t, 2026.
12M FY’26 HIGHLIGHTS
- Highest ever Revenue recorded of INR 16,794 mn, growth of 21% YoY
- Highest ever EBITDA recorded of INR 4,443 mn, growth of 20% YoY, with EBITDA margin of 26.5%
- Highest ever Net Profit recorded of INR 2,736 mn, growth of 27% YoY, with Net Profit margin of 16.3%, expansion of 83 bps YoY
- Cash from operations of INR 3,291 mn
- Significant reduction in debtor days from 161 days on 31.3.25 to 129 days on 31.3.26
- Negligible Term bank Debt of 282 mn as of 31st March 2026
- Strong liquidity with INR 3,141 mn in Fixed Deposits. Total Cash & cash equivalent (including other balances) of INR 5,509 mn
Growth Highlights
- 20% Capacity Addition- 610 beds added (highest in a year) through acquisitions in Bhatinda (250 beds) and Agra
- {360 beds, our largest acquisition till date), taking bed capacity to 3,610 beds as of 3pt March 2026
- Completed construction of our largest-ever greenfield hospital in Panchkula {350 beds) and its subsequent commissioning on 10thApr’26, taking our bed capacity to 3,960 beds as on date
- Completion of acquisition of Febris Multi-Superspeciality Hospital (200 beds) in Narela, Delhi. The facility is expected to get commissioned in Q2 FY’27
- Secured requisite approvals for 150-bed expansion at Mohali facility, taking its total capacity to 500 beds; expected to be operational within 12-15 months, making the Company the largest private healthcare provider in the Tricity region with 850 beds on completion
Q4 FY’26 HIGHLIGHTS
- Highest ever Revenue recorded of INR 4,604 mn, growth of 30% YoY
- Highest ever EBITDA recorded of INR 1,274 mn, growth of 44% YoY, with EBITDA margin of 27.7%, growth of 268 bps YoY
- Highest ever Net Profit recorded of INR 768 mn, growth of 47% YoY, with Net Profit margin of 16.7%, growth of 188 bps YoY
KEY CONSOLIDATED FINANCIAL SUMMARY:
| Particulars (INR mn) | Q4 FY’26 | Q4 FY’25 | YoY% | 12M | 12M | YoY% |
| FY’26 | FY’25 | |||||
| Revenue from Operations | 4,604 | 3,539 | 30% | 16,794 | 13,936 | 21% |
| EBITDA (ex-Other Income) | 1,274 | 884 | 44% | 4,443 | 3,710 | 20% |
| EBITDA Margin (%) | 27.70% | 25.00% | 268 bps | 26.50% | 26.60% | -16 bps |
| Net Profit | 768 | 524 | 47% | 2,736 | 2,154 | 27% |
| Net Profit Margin (%) | 16.70% | 14.80% | 188 bps | 16.30% | 15.50% | 83 bps |
| EPS {INR) | 1.78 | 1.36 | 31% | 6.87 | 5.6 | 23% |
Commenting on the overall performance of the Company, Dr. Ajit Gupta, Chairman and Dr. Ankit Gupta, Managing Director, Park Medi World, said, “FY’26 was the finest year in Park Medi World’s history – a year in which we delivered record financial and operating performance, executed our largest-ever capacity addition, and strengthened our balance sheet, all simultaneously. That combination – growth, profitability, and financial discipline moving in the same direction at the same time – is the clearest possible validation of the model we have built over two decades.
Post our IPO, we remain firmly focused on disciplined capital allocation, balance sheet strength, and measured expansion. Our immediate priorities are the seamless integration of acquired assets, improving utilisation across newer facilities, and sustaining the profitability that we have delivered. Over the medium term, we will continue to selectively pursue growth opportunities while maintaining our unwavering commitment to delivering affordable, high-quality healthcare and creating long-term value for all our stakeholders.”
Leave a Reply